Difficulty swallowing is the main symptom of eosinophilic esophagitis (EoE). EoE symptoms often get worse when you're exposed to food or environmental allergens. Getting medical help right away is ...
Food impaction can occur in people who have eosinophilic esophagitis (EoE). Find out what to do in this urgent situation.
Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up (BPT) – Do you find it difficult to swallow food? Does food feel ...
We’ve all seen them and some of us even have one at home: picky eaters. A toddler that just won’t eat, no matter what you put on their plate, may be just a phase, but experts say it could be an ...
While dupilumab's use has been extended to children under 12, benralizumab shows no benefit to patients with eosinophilic esophagitis (EoE). Despite high hopes, a drug that wipes out the namesake cell ...
Please provide your email address to receive an email when new articles are posted on . Children with eosinophilic esophagitis currently rely on elimination diets. The safety profile for this age ...
The 3 main treatments for EoE are medication, dietary therapy, or mechanical dilation of the esophagus. Patients should be evaluated individually to address their most problematic complaints first, ...
Philadelphia, August 15, 2025 – Researchers from Children’s Hospital of Philadelphia (CHOP) and Children’s Hospital Colorado have found that better control of chronic eosinophilic esophagitis ...
In the US, veterans with atopic diseases were more likely to develop eosinophilic esophagitis (EoE) than those without, with food allergies showing the strongest association. Overall, 26% (288,193) ...
The US Food and Drug Administration approvals of dupilumab (Dupixent, Regeneron/Sanofi) for adults and children with eosinophilic esophagitis (EoE) affirmed the safety and efficacy of the drug, which ...
NEW ORLEANS and CAMBRIDGE, United Kingdom, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo” or the “Company”), a company developing therapies that reset the immune system to achieve ...
Study found that stiffness of the esophagus could serve as an important biomarker for disease progression and indicate which patients may benefit the most from current therapies PHILADELPHIA, Aug. 15, ...